Researchers demonstrate first successful targeted removal of extra chromosome 21 in Down syndrome cells using CRISPR-Cas9, achieving up to 30.6% effectiveness in laboratory studies.
New AAP clinical report outlines a three-step screening strategy for primary care providers to identify biliary atresia in infants by 2-4 weeks of life, potentially reducing the need for liver transplants.